Strategic Timing of AntiRetroviral Treatment (START)

You are here

Research Type: 
Research Duration: 
December 2017
Sponsors, Funders Partners: 

The main objective is to assess the development of serious illness or AIDS when ART is initiated at fairly highCD4+ Compared to waiting until the CD4+ count is at the level where there is good evidence for starting therapy.